Agency Forms Undergoing Paperwork Reduction Act Review, 29350-29351 [2012-11878]

Download as PDF 29350 Federal Register / Vol. 77, No. 96 / Thursday, May 17, 2012 / Notices communications and constituency relations plan; and, (3) ensuring that all communications activities are developed and implemented consistent with and in support of this plan. The Office’s activities promote ONC’s broader mission of the nationwide implementation of interoperable health information technology in both the public and private health care sectors. Such activities include identifying ways to increase awareness of the value of electronic health records (EHRs) to improve health care and to create awareness of the HITECH Act provisions among all stakeholders. X. Delegation of Authority. Pending further delegation, directives or orders by the Secretary or by the National Coordinator for Health Information Technology, all delegations and redelegations of authority made to officials and employees of affected organizational components will continue in them or their successors pending further redelegations, provided they are consistent with this reorganization. Dated: May 7, 2012. E.J. Holland, Jr., Assistant Secretary for Administration. [FR Doc. 2012–11910 Filed 5–16–12; 8:45 am] BILLING CODE 4150–24–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–12–12EL] Agency Forms Undergoing Paperwork Reduction Act Review mstockstill on DSK6TPTVN1PROD with NOTICES The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). To request a copy of these requests, call (404) 639–7570 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Critical Thinking and Cultural Affirmation (CTCA): Evaluation of a Locally Developed HIV Prevention Intervention—New—National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). VerDate Mar<15>2010 17:20 May 16, 2012 Jkt 226001 Background and Brief Description In 2005, the Centers for Disease Control and Prevention (CDC) reported that 80,187 African Americans were diagnosed with HIV/AIDS, which represents 51% of persons diagnosed. African-American men with HIV/AIDS represented 44% of all cases among males (Centers for Disease Control and Prevention [CDC], 2005). These statistics have been consistently disproportional since the late 1990s, with African Americans bearing the greatest burden of new HIV cases in most regions of the United States. The Centers for Disease Control and Prevention estimates that at the end of 2006, Blacks were disproportionately affected by HIV. The 2006 HIV infection rate in Blacks was nearly twice the rate of Whites (92 out of every 100,000 Blacks compared to 48 per 100,000 Whites and 31 per 100,000 Hispanics). Among males, Black males accounted for the largest number of diagnosed HIV infections and have the highest HIV infection rate of any race/ ethnicity group (144 per 100,000, compared to 94 per 100,000 for White males and 50 per 100,000 for Hispanic males While many HIV prevention and intervention studies include samples of African-American men and AfricanAmerican Men who have Sex with Men (AAMSM), beyond demonstrating disparities in seroprevalence between and among racial groups, few have been specifically designed and evaluated for efficacy among African American men. Because few HIV prevention interventions targeting AAMSM have been developed and rigorously evaluated, while their HIV infection rates remain disproportionately high and continue to rise, identifying effective interventions for AAMSM is a public health imperative. The purpose of this project is to test the efficacy of an HIV transmission prevention intervention for reducing sexual risk among African American men who have sex with men in Chicago, Illinois. The intervention is a 3-day weekend retreat, group-level CTCA intervention that combines cultural affirmation with critical thinking and empowerment, to increase reasoning skill, problem solving capacity, selfprotective behavior change, and wellbeing which facilitates the reduction of risky sexual behaviors. A convenience sample of 438 AAMSM will be recruited to participate in the study. We anticipate recruiting potential participants for the CTCA RCT through a variety of community venues, using both active (i.e., venue outreach) and passive (i.e., referral, flyers/handcards, PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Internet) recruitment techniques. The intervention will be evaluated using baseline, 3-month and 6-month follow up assessments. This project will also conduct exit surveys to identify men who were more favorable—men who agreed with positive comments about the intervention and those who were less favorable—men who disagreed with positive comments about the intervention. Exit interviews will be conducted with 15 favorable and 15 less favorable men identified by the Exit Survey to help understand participants’ experiences with the CTCA intervention and their thoughts about the content of the intervention and ways in which it could be improved. Using the participant responses to the exit survey, we will categorize participants into two categories: Favorable (those men reporting a favorable reaction to the intervention) and unfavorable (those men reporting an unfavorable reaction to the intervention). Once we have 50 participants in each category, we will randomly select 15 participants from each group and invite them to participate in the exit interview. We anticipate that we will need to repeat these procedures and extend an invitation to at least 65 participants in order to reach and successfully interview 15 participants in each group. CDC is requesting approval for a 3-year clearance for data collection. The data collection system involves a pre and full screening, brief locator information, record locator information, baseline assessment, 3-month follow-up assessment, 6-month follow-up assessment, participant evaluation forms, exit survey, and exit interviews. An estimated 1000 men will be prescreened and 515 will be full-screened for eligibility in order to enroll 438 men. The baseline and follow up questionnaires will be administered electronically using audio computer assisted self-interview (ACASI). The ACASI interview includes questions about participants’ socio-demographic information, health and healthcare, sexual activity, substance use, and other psychosocial issues. The duration of each baseline, 3-month, and 6-month assessments are estimated to be 60 minutes; the exit survey 10 minutes; the exit interview 30 minutes; pre-screening form 5 minutes; full-screening form 10 minutes; brief locator information form 5 minutes; record locator information form 10 minutes; each participant evaluation survey 5 minutes. There is no cost to participants other than their time. The total estimated annual burden hours are 527. E:\FR\FM\17MYN1.SGM 17MYN1 29351 Federal Register / Vol. 77, No. 96 / Thursday, May 17, 2012 / Notices Number of respondents Type of respondent Form name Prospective Study Participant ................................................. Prospective Study Participant ................................................. Prospective Study Participant ................................................. Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Pre-Screening Form ............... Full-Screening Form ............... Brief Locator Form ................. Record Locator Form ............. Baseline Assessment ............. 3-month Follow-up Assessment. 6-month Follow-up Assessment. Participant Evaluation Forms Exit Survey ............................. Exit Interview .......................... Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Enrolled Study Participant ...................................................... Kimberly S. Lane, Deputy Director, Office of Science Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. a.m. to 5:30 p.m., EST and Thursday, June 21, 2012 from 8:30 a.m. to 1:00 p.m. EST. Logistics: The Task Force Meeting will be held at the Emory Conference Center’s at 1615 Clifton Road Atlanta, GA 30329. Information regarding logistics will be available on the Community Guide Web site (www.thecommunityguide.org), Wednesday, May 23, 2012. [FR Doc. 2012–11878 Filed 5–16–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention FOR FURTHER INFORMATION CONTACT: Meeting of the Community Preventive Services Task Force (CPSTF) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The Centers for Disease Control and Prevention (CDC) announces the next meeting of the Community Preventive Services Task Force (CPSTF). The Task Force—an independent, nonfederal body of nationally known leaders in public health practice, policy, and research, who are appointed by the CDC Director—was convened in 1996 by the Department of Health and Human Services (HHS) to assess the effectiveness of community, environmental, population, and healthcare system interventions in public health and health promotion. During this meeting, the Task Force will consider the findings of systematic reviews and issue recommendations and findings to help inform decision making about policy, practice, and research in a wide range of U.S. settings. The Task Force’s recommendations, along with the systematic reviews of the scientific evidence on which they are based, are compiled in the Guide to Community Preventive Services (Community Guide). DATES: The meeting will be held on Wednesday, June 20, 2012 from 8:30 mstockstill on DSK6TPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:20 May 16, 2012 Jkt 226001 Allyson Brown, The Community Guide Branch, Epidemiology and Analysis Program Office, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, 1600 Clifton Road, MS–E– 69, Atlanta, Georgia 30333, phone: (404) 498–0937), email: CPSTF@cdc.gov. Purpose: The purpose of the meeting is for the Task Force to consider the findings of systematic reviews and issue recommendations and findings to help inform decision making about policy, practice, and research in a wide range of U.S. settings. Matters To Be Discussed: Updates on Cancer, Motor vehicle-related injuries, Tobacco, Health Equity, and Alcohol. Meeting Accessibility: This meeting is open to the public, limited only by space availability. Dated: May 3, 2012. Tanja Popovic, Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2012–11938 Filed 5–16–12; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Number responses per respondent Average burden per respondent (in hours) 333 172 172 146 146 132 1 1 1 1 1 1 5/60 10/60 5/60 10/60 1 1 117 1 1 146 117 10 6 1 1 5/60 10/60 30/60 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control; Special Interest Projects (SIPs): Initial Review The meeting announced below concerns Examination of Environmental Characteristics that Enable and/or Promote Frequent Indoor Tanning among Young Adults to Inform Future Public Health Policy Efforts to Prevent Skin Cancer, SIP12–054, Pilot Study to Evaluate Strategies for Reducing Medical Radiation Exposure in Children, SIP12–055, and Innovative Message Framing to Increase Support for Evidence-based Tobacco Control, SIP12–060, Panel A, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date 11:00 a.m.–5:30 p.m., June 20, 2012 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Examination of Environmental Characteristics that Enable and/or Promote Frequent Indoor Tanning among Young Adults to Inform Future Public Health Policy Efforts to Prevent Skin Cancer, SIP12–054, Pilot Study to Evaluate Strategies for Reducing Medical Radiation Exposure in E:\FR\FM\17MYN1.SGM 17MYN1

Agencies

[Federal Register Volume 77, Number 96 (Thursday, May 17, 2012)]
[Notices]
[Pages 29350-29351]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-11878]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-12-12EL]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. chapter 35). To request a copy of these requests, call 
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments 
to CDC Desk Officer, Office of Management and Budget, Washington, DC 
20503 or by fax to (202) 395-5806. Written comments should be received 
within 30 days of this notice.

Proposed Project

    Critical Thinking and Cultural Affirmation (CTCA): Evaluation of a 
Locally Developed HIV Prevention Intervention--New--National Center for 
HIV/AIDS, Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    In 2005, the Centers for Disease Control and Prevention (CDC) 
reported that 80,187 African Americans were diagnosed with HIV/AIDS, 
which represents 51% of persons diagnosed. African-American men with 
HIV/AIDS represented 44% of all cases among males (Centers for Disease 
Control and Prevention [CDC], 2005). These statistics have been 
consistently disproportional since the late 1990s, with African 
Americans bearing the greatest burden of new HIV cases in most regions 
of the United States. The Centers for Disease Control and Prevention 
estimates that at the end of 2006, Blacks were disproportionately 
affected by HIV. The 2006 HIV infection rate in Blacks was nearly twice 
the rate of Whites (92 out of every 100,000 Blacks compared to 48 per 
100,000 Whites and 31 per 100,000 Hispanics). Among males, Black males 
accounted for the largest number of diagnosed HIV infections and have 
the highest HIV infection rate of any race/ethnicity group (144 per 
100,000, compared to 94 per 100,000 for White males and 50 per 100,000 
for Hispanic males
    While many HIV prevention and intervention studies include samples 
of African-American men and African-American Men who have Sex with Men 
(AAMSM), beyond demonstrating disparities in seroprevalence between and 
among racial groups, few have been specifically designed and evaluated 
for efficacy among African American men. Because few HIV prevention 
interventions targeting AAMSM have been developed and rigorously 
evaluated, while their HIV infection rates remain disproportionately 
high and continue to rise, identifying effective interventions for 
AAMSM is a public health imperative.
    The purpose of this project is to test the efficacy of an HIV 
transmission prevention intervention for reducing sexual risk among 
African American men who have sex with men in Chicago, Illinois. The 
intervention is a 3-day weekend retreat, group-level CTCA intervention 
that combines cultural affirmation with critical thinking and 
empowerment, to increase reasoning skill, problem solving capacity, 
self-protective behavior change, and well-being which facilitates the 
reduction of risky sexual behaviors. A convenience sample of 438 AAMSM 
will be recruited to participate in the study. We anticipate recruiting 
potential participants for the CTCA RCT through a variety of community 
venues, using both active (i.e., venue outreach) and passive (i.e., 
referral, flyers/handcards, Internet) recruitment techniques. The 
intervention will be evaluated using baseline, 3-month and 6-month 
follow up assessments. This project will also conduct exit surveys to 
identify men who were more favorable--men who agreed with positive 
comments about the intervention and those who were less favorable--men 
who disagreed with positive comments about the intervention. Exit 
interviews will be conducted with 15 favorable and 15 less favorable 
men identified by the Exit Survey to help understand participants' 
experiences with the CTCA intervention and their thoughts about the 
content of the intervention and ways in which it could be improved. 
Using the participant responses to the exit survey, we will categorize 
participants into two categories: Favorable (those men reporting a 
favorable reaction to the intervention) and unfavorable (those men 
reporting an unfavorable reaction to the intervention). Once we have 50 
participants in each category, we will randomly select 15 participants 
from each group and invite them to participate in the exit interview. 
We anticipate that we will need to repeat these procedures and extend 
an invitation to at least 65 participants in order to reach and 
successfully interview 15 participants in each group.
    CDC is requesting approval for a 3-year clearance for data 
collection. The data collection system involves a pre and full 
screening, brief locator information, record locator information, 
baseline assessment, 3-month follow-up assessment, 6-month follow-up 
assessment, participant evaluation forms, exit survey, and exit 
interviews. An estimated 1000 men will be pre-screened and 515 will be 
full-screened for eligibility in order to enroll 438 men. The baseline 
and follow up questionnaires will be administered electronically using 
audio computer assisted self-interview (ACASI). The ACASI interview 
includes questions about participants' socio-demographic information, 
health and healthcare, sexual activity, substance use, and other 
psychosocial issues. The duration of each baseline, 3-month, and 6-
month assessments are estimated to be 60 minutes; the exit survey 10 
minutes; the exit interview 30 minutes; pre-screening form 5 minutes; 
full-screening form 10 minutes; brief locator information form 5 
minutes; record locator information form 10 minutes; each participant 
evaluation survey 5 minutes.
    There is no cost to participants other than their time. The total 
estimated annual burden hours are 527.

[[Page 29351]]



----------------------------------------------------------------------------------------------------------------
                                                                                      Number      Average burden
          Type of respondent                    Form name            Number of     responses per  per respondent
                                                                    respondents     respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
Prospective Study Participant.........  Pre-Screening Form......             333               1            5/60
Prospective Study Participant.........  Full-Screening Form.....             172               1           10/60
Prospective Study Participant.........  Brief Locator Form......             172               1            5/60
Enrolled Study Participant............  Record Locator Form.....             146               1           10/60
Enrolled Study Participant............  Baseline Assessment.....             146               1               1
Enrolled Study Participant............  3-month Follow-up                    132               1               1
                                         Assessment.
Enrolled Study Participant............  6-month Follow-up                    117               1               1
                                         Assessment.
Enrolled Study Participant............  Participant Evaluation               146               6            5/60
                                         Forms.
Enrolled Study Participant............  Exit Survey.............             117               1           10/60
Enrolled Study Participant............  Exit Interview..........              10               1           30/60
----------------------------------------------------------------------------------------------------------------


Kimberly S. Lane,
Deputy Director, Office of Science Integrity, Office of the Associate 
Director for Science, Office of the Director, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-11878 Filed 5-16-12; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.